Cargando…

Surgical Options in Treating Patients with Primary Hyperparathyroidism

BACKGROUND: Primary hyperparathyroidism is the third most common endocrine disorder for which surgical procedure called parathyroidectomy is the most effective treatment. Since the early 20(th) century, parathyroid surgery has improved extensively. With the advances in preoperative imaging and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Majcen, Masa, Hocevar, Marko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087427/
https://www.ncbi.nlm.nih.gov/pubmed/32114525
http://dx.doi.org/10.2478/raon-2020-0010
_version_ 1783509334147203072
author Majcen, Masa
Hocevar, Marko
author_facet Majcen, Masa
Hocevar, Marko
author_sort Majcen, Masa
collection PubMed
description BACKGROUND: Primary hyperparathyroidism is the third most common endocrine disorder for which surgical procedure called parathyroidectomy is the most effective treatment. Since the early 20(th) century, parathyroid surgery has improved extensively. With the advances in preoperative imaging and with understanding the causes of disease, new and minimally invasive surgical approaches overrode the standard bilateral exploratory operations. Directed parathyroidectomy is currently the standard technique for treatment of primary hyperparathyroidism worldwide. CONCLUSIONS: Surgery is the only definitive treatment of primary hyperparathyroidism. The most appropriate type of surgical procedure depends on the number and localization of the hyperactive parathyroid glands, availability of modern imaging techniques, limitation of each type of procedure and expertise.
format Online
Article
Text
id pubmed-7087427
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-70874272020-03-26 Surgical Options in Treating Patients with Primary Hyperparathyroidism Majcen, Masa Hocevar, Marko Radiol Oncol Review BACKGROUND: Primary hyperparathyroidism is the third most common endocrine disorder for which surgical procedure called parathyroidectomy is the most effective treatment. Since the early 20(th) century, parathyroid surgery has improved extensively. With the advances in preoperative imaging and with understanding the causes of disease, new and minimally invasive surgical approaches overrode the standard bilateral exploratory operations. Directed parathyroidectomy is currently the standard technique for treatment of primary hyperparathyroidism worldwide. CONCLUSIONS: Surgery is the only definitive treatment of primary hyperparathyroidism. The most appropriate type of surgical procedure depends on the number and localization of the hyperactive parathyroid glands, availability of modern imaging techniques, limitation of each type of procedure and expertise. Sciendo 2020-02-29 /pmc/articles/PMC7087427/ /pubmed/32114525 http://dx.doi.org/10.2478/raon-2020-0010 Text en © 2020 Masa Majcen, Marko Hocevar, published by Sciendo http://creativecommons.org/licenses/by-nc-nd/3.0 This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
spellingShingle Review
Majcen, Masa
Hocevar, Marko
Surgical Options in Treating Patients with Primary Hyperparathyroidism
title Surgical Options in Treating Patients with Primary Hyperparathyroidism
title_full Surgical Options in Treating Patients with Primary Hyperparathyroidism
title_fullStr Surgical Options in Treating Patients with Primary Hyperparathyroidism
title_full_unstemmed Surgical Options in Treating Patients with Primary Hyperparathyroidism
title_short Surgical Options in Treating Patients with Primary Hyperparathyroidism
title_sort surgical options in treating patients with primary hyperparathyroidism
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087427/
https://www.ncbi.nlm.nih.gov/pubmed/32114525
http://dx.doi.org/10.2478/raon-2020-0010
work_keys_str_mv AT majcenmasa surgicaloptionsintreatingpatientswithprimaryhyperparathyroidism
AT hocevarmarko surgicaloptionsintreatingpatientswithprimaryhyperparathyroidism